Jupiter Neurosciences

(NASDAQ) JUNS

Current Price$0.38

Market Cap$13.08M

Since IPO (2024)-93%

5 YearN/A

1 Year-42%

1 Month-2%

Jupiter Neurosciences Financials at a Glance

Market Cap

$13.08M

Revenue (TTM)

$21.80K

Net Income (TTM)

$8.64M

EPS (TTM)

$-0.26

P/E Ratio

-1.41

Dividend

$0.00

Beta (Volatility)

0.37 (Low)

Dividend

$0.00

Beta (Volatility)

0.37 (Low)

Price

$0.38

Volume

186

Open

$0.38

Price

$0.38

Volume

186

Open

$0.38

Previous Close

$0.38

Daily Range

$0.38 - $0.38

52-Week Range

$0.31 - $3.33

Dividend

$0.00

Beta (Volatility)

0.37 (Low)

Price

$0.38

Volume

186

Open

$0.38

Previous Close

$0.38

Daily Range

$0.38 - $0.38

52-Week Range

$0.31 - $3.33

JUNS News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Jupiter Neurosciences

Industry

Pharmaceuticals

Sector

Health Care

Employees

CEO

Christer Rosén

Website

www.jupiterneurosciences.com

Headquarters

Jupiter, FL 33477, US

JUNS Financials

Key Financial Metrics (TTM)

Gross Margin

100%

Operating Margin

-409%

Net Income Margin

-397%

Return on Equity

-739%

Return on Capital

Return on Assets

-2%

Earnings Yield

-70.92%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$13.08M

Shares Outstanding

36.28M

Volume

186

Avg. Volume

124.83K

Financials (TTM)

Gross Profit

$17.57K

Operating Income

$8.91M

EBITDA

$8.58M

Operating Cash Flow

$5.41M

Capital Expenditure

$4.00

Free Cash Flow

$5.41M

Cash & ST Invst.

$3.79M

Total Debt

$5.32M

Jupiter Neurosciences Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q4 2025YOY CHG

Revenue

$21.80K

N/A

Gross Profit

$21.80K

N/A

Gross Margin

100.00%

N/A

Market Cap

$13.08M

N/A

Market Cap/Employee

$3.27M

N/A

Employees

N/A

Net Income

$2.58M

-68.6%

EBITDA

$2.51M

-67.8%

Quarterly Fundamentals

Name

Q4 2025YOY CHG

Net Cash

$1.53M

-143.1%

Accounts Receivable

$0.00

N/A

Inventory

$159.79K

N/A

Long Term Debt

$0.00

-100.0%

Short Term Debt

$5.32M

+2606.8%

Return on Assets

-1.55%

N/A

Return on Invested Capital

4.86%

N/A

Free Cash Flow

$2.37M

+35.9%

Operating Cash Flow

$2.37M

+35.9%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

GNTAGenenta Science S.p.A.

GNTAGenenta Science S.p.A.$0.67-3.19%

ABVCABVC BioPharma, Inc.

ABVCABVC BioPharma, Inc.$1.03-1.90%

SKYESkye Bioscience, Inc.

SKYESkye Bioscience, Inc.$0.88+0.83%

GRCEGrace Therapeutics, Inc.

GRCEGrace Therapeutics, Inc.$2.33-1.27%

FGENFibroGen, Inc.

FGENFibroGen, Inc.$9.07-1.63%

ALGSAligos Therapeutics, Inc.

ALGSAligos Therapeutics, Inc.$6.35-1.40%

XFORX4 Pharmaceuticals, Inc.

XFORX4 Pharmaceuticals, Inc.$4.20-0.24%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

INTCIntel

INTCIntel$108.15+0.13%

DGXXDigi Power X

DGXXDigi Power X$5.11+0.29%

NOKNokia

NOKNokia$13.42+0.02%

POETPoet Technologies

POETPoet Technologies$9.21+0.30%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$12.96-0.02%

CCLCarnival Corp.

CCLCarnival Corp.$25.77+0.00%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.81+0.02%

Questions About JUNS

What is the current price of Jupiter Neurosciences?

Jupiter Neurosciences is trading at $0.38 per share.

What is the 52-week range for Jupiter Neurosciences?

Over the past 52 weeks, Jupiter Neurosciences has traded between $0.31 and $3.33.

How much debt does Jupiter Neurosciences have?

As of the most recent reporting period, Jupiter Neurosciences reported total debt of $5.32M.

How much cash does Jupiter Neurosciences have on hand?

Jupiter Neurosciences reported $3.79M in cash and cash equivalents in its most recent financial results.

What is Jupiter Neurosciences’s dividend yield?

Jupiter Neurosciences does not currently have a dividend yield.

Jupiter Neurosciences

Jupiter Neurosciences Financials at a Glance

JUNS News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Jupiter Neurosciences

JUNS Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Jupiter Neurosciences Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About JUNS

What is the current price of Jupiter Neurosciences?

What is the 52-week range for Jupiter Neurosciences?

How much debt does Jupiter Neurosciences have?

How much cash does Jupiter Neurosciences have on hand?

What is Jupiter Neurosciences’s dividend yield?

Premium Investing Services